{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:20Z","timestamp":1790983100410,"version":"4.1.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Methotrexate neurotoxicity is a recognized complication in pediatric lymphoid malignancies, presenting with seizures, stroke-like episodes, or leukoencephalopathy. Catatonia is a rare and underrecognized manifestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Observation:<\/jats:title>\n                    <jats:p>A 13-year-old girl with T-cell lymphoblastic lymphoma developed agitation, confusion, and catatonia 5 days after intrathecal methotrexate. Investigations excluded structural, infectious, metabolic, and malignant causes. Psychiatry confirmed catatonia (Bush-Francis Catatonia Rating Scale 21-22). Lorazepam led to rapid improvement. Intrathecal methotrexate was later reintroduced with leucovorin rescue without recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Catatonia may represent an uncommon presentation of methotrexate neurotoxicity. Early recognition and lorazepam treatment are critical, and cautious methotrexate rechallenge may be feasible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003265","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:00:09Z","timestamp":1787839209000},"page":"361-363","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Catatonia in a 13-Year-Old With T-Cell Lymphoblastic Lymphoma Following Intrathecal Methotrexate"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5031-6363","authenticated-orcid":false,"given":"Raquel","family":"Lazarowitz","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health Sciences, McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Picado","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Montreal Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Stankova","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"R1-20260928","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.20.00531","article-title":"Successful outcomes of newly diagnosed T lymphoblastic lymphoma: results from Children\u2019s Oncology Group AALL0434","volume":"38","author":"Hayashi","year":"2020","journal-title":"J Clin Oncol"},{"key":"R2-20260928","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/annonc\/mdm466","article-title":"Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer","volume":"19","author":"Inaba","year":"2008","journal-title":"Ann Oncol"},{"key":"R3-20260928","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","article-title":"Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus","volume":"17","author":"Schmiegelow","year":"2016","journal-title":"Lancet Oncol"},{"key":"R4-20260928","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.19559","article-title":"Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia\/lymphoma: experience from a tertiary care centre in South India","volume":"205","author":"Rupakumar","year":"2024","journal-title":"Br J Haematol"},{"key":"R5-20260928","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJMra2116304","article-title":"Catatonia","volume":"389","author":"Heckers","year":"2023","journal-title":"N Engl J Med"},{"key":"R6-20260928","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.21873\/anticanres.17694","article-title":"Ifosfamide-induced catatonia - a rare presentation and review of ifosfamide-induced central nervous system toxicity along with therapeutic approaches","volume":"45","author":"Lyndon","year":"2025","journal-title":"Anticancer Res"},{"key":"R9-20260928","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","article-title":"Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia","volume":"32","author":"Bhojwani","year":"2014","journal-title":"J Clin Oncol"},{"key":"R10-20260928","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.toxlet.2018.11.016","article-title":"Methotrexate induces astrocyte apoptosis by disrupting folate metabolism in the mouse juvenile central nervous system","volume":"301","author":"Shao","year":"2019","journal-title":"Toxicol Lett"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:00:20Z","timestamp":1790622020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003265","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"2026-02-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}